872P Ipilimumab-induced gastrointestinal and hepatic immune-related adverse events: A national cohort. - Langbein, B.; Labban, M.; Chen, X.; Reese, S.; Lipsitz, S.; McNabb-Baltar, J.; Sun, M.; Cole, A.; Trinh, Q-D. (Annals of Oncology, 2022)